BETTER BUILDINGS FOR BETTER PHARMACEUTICAL PRODUCTION

May 28, 2019

Embracing and investing in new technologies is one way to get ahead, and adopting lean, efficient manufacturing procedures is another. At a fundamental level, achieving efficiency can start at the outset of a project by considering the very design of a production facility. Careful planning can cut costs and reduce waste at all stages, while at the same time ensuring the production of quality products. For both new entrants wishing to establish a position in the sector, and for established OSD producers seeking to successfully expand their product ranges, getting the end product consistently right is, of course, crucial. In this article, we take a look beyond the processes involved in drug manufacture itself, and instead turn our attention to an often overlooked and underappreciated factor of the manufacturing process: that of materials handling.

Spotlight

Reach Separations

Reach Separations specialises in chromatography for the analysis and purification of small molecules. We provide a high quality and efficient service to our clients returning samples and results quickly, allowing them to streamline their internal processes and accelerate their discovery programmes. The latest HPLC and SFC technologies are used side by side to effectively support our clients across the pharmaceutical, agrochemical and fine chemical sectors. As experts in chiral separation we have become an economical solution for a large and varied client base throughout the UK and Europe.

OTHER WHITEPAPERS
news image

The Key to Commercializing Revolutionary Gene Therapiesand Other Orphan Drugs

whitePaper | October 27, 2022

In today’s evolving, value-based environment for specialty drugs, hightouch services that enhance patient outcomes are playing an increasingly important role in market access and patient care delivery

Read More
news image

A pragmatic approach to developing rare disease drug

whitePaper | July 13, 2023

Most medicines in development today target diseases affecting large sections of the global population. But now we are slowly beginning to see a rise in the interest of developing ”orphan drugs,” or pharmaceutical agents intended to treat rare diseases.

Read More
news image

Transforming Patient Journey in Clinical Trials

whitePaper | April 7, 2022

Year after year, the Life Sciences industry expands at a breakneck pace, with pharmaceutical development leading the way.

Read More
news image

Deck 7 Webinars and Virtual Events

whitePaper | January 1, 2020

If you recognize some of these challenges, download the Deck 7 Webinar & Virtual Events overview to see how we make it easy for busy marketers to run highly successful webinars and virtual events....

Read More
news image

Global Use of Medicines 2023

whitePaper | January 18, 2023

Reaching a post-pandemic era is an alluring prospect for almost everyone around the world after the disruptions of the past three years.

Read More
news image

A Brief Synopsis of Modern Randomization Methodologies and Technologies

whitePaper | December 9, 2022

Randomized, double-blind clinical trials are the gold standard for adequate and well-controlled studies in modern times. However, prior to the late 1940s, randomization and blinding were not used in medicine and as result, bias was common.

Read More

Spotlight

Reach Separations

Reach Separations specialises in chromatography for the analysis and purification of small molecules. We provide a high quality and efficient service to our clients returning samples and results quickly, allowing them to streamline their internal processes and accelerate their discovery programmes. The latest HPLC and SFC technologies are used side by side to effectively support our clients across the pharmaceutical, agrochemical and fine chemical sectors. As experts in chiral separation we have become an economical solution for a large and varied client base throughout the UK and Europe.

Events